Pilloried for their role in the epidemic of prescription painkiller abuse, drugmakers are pushing their remedy: a new generation of harder-to-manipulate opioids that have racked up billions in sales, though there's little proof they reduce rates of overdoses or deaths, the Associated Press reports. More than prescriptions are at stake. Critics worry the drugmakers' nationwide lobbying campaign is distracting from more productive . . .
Want to read more? Please subscribe to The Crime Report!